These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 16179127

  • 1. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
    Dodig S, Richter D, Cepelak I, Benko B.
    Acta Pharm; 2005 Jun; 55(2):123-38. PubMed ID: 16179127
    [Abstract] [Full Text] [Related]

  • 2. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L, Sorkness CA.
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [Abstract] [Full Text] [Related]

  • 3. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
    Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N.
    J Allergy Clin Immunol; 2001 Aug; 108(2):184-90. PubMed ID: 11496232
    [Abstract] [Full Text] [Related]

  • 4. Omalizumab as add-on therapy to inhaled steroids for asthma.
    Hadj Tahar A.
    Issues Emerg Health Technol; 2004 Jun; (58):1-4. PubMed ID: 15455487
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M, Fox H, Surrey K.
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [Abstract] [Full Text] [Related]

  • 6. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):302-7. PubMed ID: 16464445
    [Abstract] [Full Text] [Related]

  • 7. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST, Djukanović R, Casale T, Bousquet J.
    Clin Exp Allergy; 2005 Apr 08; 35(4):408-16. PubMed ID: 15836747
    [Abstract] [Full Text] [Related]

  • 8. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D.
    Respir Med; 2006 Nov 08; 100(11):1907-17. PubMed ID: 16949266
    [Abstract] [Full Text] [Related]

  • 9. Anti-IgE therapy of asthma.
    Chung KF.
    Curr Opin Investig Drugs; 2002 Aug 08; 3(8):1157-60. PubMed ID: 12211407
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Omalizumab (Xolair). Product description].
    Laursen LC.
    Ugeskr Laeger; 2007 Mar 12; 169(11):993-5. PubMed ID: 17371630
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease.
    Berger WE.
    Ann Allergy Asthma Immunol; 2002 Feb 12; 88(2):152-60; quiz 161-2, 208. PubMed ID: 11868919
    [Abstract] [Full Text] [Related]

  • 13. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C.
    J Allergy Clin Immunol; 2005 Mar 12; 115(3):459-65. PubMed ID: 15753888
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
    Holgate S, Bousquet J, Wenzel S, Fox H, Liu J, Castellsague J.
    Curr Med Res Opin; 2001 Mar 12; 17(4):233-40. PubMed ID: 11922396
    [Abstract] [Full Text] [Related]

  • 15. Omalizumab: a novel therapy for allergic asthma.
    Davis LA.
    Ann Pharmacother; 2004 Mar 12; 38(7-8):1236-42. PubMed ID: 15187202
    [Abstract] [Full Text] [Related]

  • 16. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
    Kupryś-Lipińska I, Kuna P.
    Pneumonol Alergol Pol; 2009 Mar 12; 77(1):43-51. PubMed ID: 19308909
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma.
    Ayres JG, Higgins B, Chilvers ER, Ayre G, Blogg M, Fox H.
    Allergy; 2004 Jul 12; 59(7):701-8. PubMed ID: 15180756
    [Abstract] [Full Text] [Related]

  • 18. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
    Sullivan SD, Turk F.
    Allergy; 2008 Jun 12; 63(6):670-84. PubMed ID: 18445184
    [Abstract] [Full Text] [Related]

  • 19. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G, Renda T, Romeo P, Busceti MT, Maselli R.
    Ther Adv Respir Dis; 2008 Dec 12; 2(6):409-21. PubMed ID: 19124386
    [Abstract] [Full Text] [Related]

  • 20. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis.
    Casale TB, Prous Science.
    Drugs Today (Barc); 2004 Apr 12; 40(4):367-76. PubMed ID: 15190389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.